NASH - NONALCOHOLIC STEATOHEPATITIS
Clinical trials for NASH - NONALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NASH - NONALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NASH - NONALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets reversing fatty liver disease damage
Disease control OngoingThis study is testing whether an investigational drug called HM15211 can help people with NASH, a serious form of fatty liver disease. Researchers want to see if the drug can reduce liver inflammation and scarring over 12 months of treatment. The trial involves 215 adults with a …
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Common heart pill may hold key to fighting silent liver scourge
Disease control OngoingThis study is testing if a widely used cholesterol-lowering drug, atorvastatin (Lipitor), can safely improve liver health in adults with NASH, a serious form of fatty liver disease that can lead to scarring. About 70 participants with confirmed liver damage will receive either th…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Vitamin e trial aims to halt liver decline
Disease control OngoingThis study is testing whether a natural vitamin E supplement called tocotrienol can slow the progression of advanced liver disease caused by fatty liver. About 70 patients with stable but serious liver damage will take either the supplement or a placebo twice daily for three year…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Chandan Sen • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC
-
Scientists probe Liver's inner workings to predict surgery success
Knowledge-focused OngoingThis study aims to understand how the liver's energy production changes in people with fatty liver disease (NASH) who are undergoing weight loss surgery. Researchers will measure how the liver burns fat and makes sugar in 30 participants before their surgery. The goal is to see i…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Massive 120,000-Person study aims to crack the code of chronic illness
Knowledge-focused TerminatedThis study aims to understand how genetics, lifestyle, and other factors influence the progression and severity of many common chronic diseases. Researchers will collect health records, genetic data, and samples from 120,000 participants with conditions like diabetes, arthritis, …
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC
-
Groundbreaking study seeks answers about silent liver threat in HIV community
Knowledge-focused OngoingThis study aims to understand how fatty liver disease develops and progresses in people living with HIV. Researchers will follow 400 participants for at least one year, using non-invasive scans to measure liver fat and stiffness. The goal is to fill critical knowledge gaps about …
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:22 UTC